The risk or severity of adverse effects can be increased when Suvorexant is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when spironolactone is combined with captopril.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with clonazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with doxepin.


The risk or severity of adverse effects can be increased when butamben is combined with nortriptyline.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with loratadine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with oxaprozin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Melatonin.


The risk or severity of adverse effects can be increased when diclofenac is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when alprazolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when thiopental is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when lisinopril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when amphotericin b is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Clofarabine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Carbetocin is combined with thalidomide.


The risk or severity of adverse effects can be increased when lisinopril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when lisinopril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when olanzapine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with sertraline.


The risk or severity of adverse effects can be increased when suprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with fenoprofen.


The risk or severity of adverse effects can be increased when diazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with acetazolamide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfamethizole.


The risk or severity of adverse effects can be increased when salicylic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amifostine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when fenoldopam is combined with halothane.


The risk or severity of adverse effects can be increased when Propiverine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when salicylic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when levorphanol is combined with doxepin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Lofexidine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when barnidipine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Lofexidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with isradipine.


The risk or severity of adverse effects can be increased when biperiden is combined with quinidine.


The risk or severity of adverse effects can be increased when morphine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when morphine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with zotepine.


The risk or severity of adverse effects can be increased when nabumetone is combined with amcinonide.


The risk or severity of adverse effects can be increased when zopiclone is combined with felbamate.


The risk or severity of adverse effects can be increased when amifostine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when nabumetone is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Bortezomib.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with hydralazine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with tiapride.


The risk or severity of adverse effects can be increased when nalbuphine is combined with theobromine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Treprostinil is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when thiothixene is combined with trazodone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Sorafenib.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when protriptyline is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Tianeptine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when nylidrin is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when haloperidol is combined with efavirenz.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with bupropion.


The risk or severity of adverse effects can be increased when indomethacin is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when clorazepate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clorazepate is combined with zotepine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with DESONIDE.


The risk or severity of adverse effects can be increased when hydralazine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Caspofungin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with proparacaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Flibanserin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when ethosuximide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when thiopental is combined with nefazodone.


The risk or severity of adverse effects can be increased when indomethacin is combined with carprofen.


The risk or severity of adverse effects can be increased when HEROIN is combined with scopolamine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with phenytoin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when HEROIN is combined with D-mannitol.


The risk or severity of adverse effects can be increased when mesalamine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when gabapentin is combined with meclizine.


The risk or severity of adverse effects can be increased when timolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with tiapride.


The risk or severity of adverse effects can be increased when timolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with butorphanol.


The risk or severity of adverse effects can be increased when atenolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when alprazolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when atenolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when clozapine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when meprobamate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Apremilast is combined with formestane.


The risk or severity of adverse effects can be increased when meprobamate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when morniflumate is combined with alclofenac.


The risk or severity of adverse effects can be increased when methoxamine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when thalidomide is combined with sotalol.


The risk or severity of adverse effects can be increased when Aprepitant is combined with oxycodone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with carvedilol.


The risk or severity of adverse effects can be increased when fluvastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when metoclopramide is combined with methacholine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with bromocriptine.


The risk or severity of adverse effects can be increased when levodopa is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with lomustine.


The risk or severity of adverse effects can be increased when diazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when nabumetone is combined with Apremilast.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with duloxetine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nitric oxide.


The risk or severity of adverse effects can be increased when zonisamide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Spirapril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when nabumetone is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when butenafine is combined with bepridil.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Apremilast is combined with alclofenac.


The risk or severity of adverse effects can be increased when promazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when rizatriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with tiapride.


The risk or severity of adverse effects can be increased when enalapril is combined with captopril.


The risk or severity of adverse effects can be increased when fenbufen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when nitrendipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when furosemide is combined with tizanidine.


The risk or severity of adverse effects can be increased when furosemide is combined with daunorubicin.


The risk or severity of adverse effects can be increased when nitrendipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ethosuximide is combined with dantrolene.


The risk or severity of adverse effects can be increased when oxprenolol is combined with clonazepam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with promethazine.


The risk or severity of adverse effects can be increased when triamterene is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with tizanidine.


The risk or severity of adverse effects can be increased when zaleplon is combined with prazepam.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with furosemide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with phentolamine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Lurasidone is combined with thiopental.


The risk or severity of adverse effects can be increased when trimipramine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Lurasidone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when dopamine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Flibanserin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when azelastine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with quinapril.


The risk or severity of adverse effects can be increased when tetracaine is combined with meclizine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when irbesartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Apixaban.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with metolazone.


The risk or severity of adverse effects can be increased when reserpine is combined with felbamate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when celecoxib is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Fospropofol is combined with phenytoin.


The risk or severity of adverse effects can be increased when ethosuximide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with trazodone.


The risk or severity of adverse effects can be increased when quazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with diflorasone.


The risk or severity of adverse effects can be increased when oxiconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with difluprednate.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when pentamidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when THYMOL is combined with isradipine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Isometheptene.


The risk or severity of adverse effects can be increased when roxithromycin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when salicylamide is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when meprobamate is combined with Retigabine.


The risk or severity of adverse effects can be increased when clozapine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when lisinopril is combined with indapamide.


The risk or severity of adverse effects can be increased when itraconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when ketorolac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with astemizole.


The risk or severity of adverse effects can be increased when naratriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Normethadone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when trandolapril is combined with terazosin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when leflunomide is combined with nimesulide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when alprazolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Micafungin is combined with diltiazem.


The risk or severity of adverse effects can be increased when Melatonin is combined with carisoprodol.


The risk or severity of adverse effects can be increased when buspirone is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with quinapril.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with nimesulide.


The risk or severity of adverse effects can be increased when itraconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when Naftifine is combined with difluprednate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ticlopidine.


The risk or severity of adverse effects can be increased when buspirone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with sulpiride.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sildenafil.


The risk or severity of adverse effects can be increased when methylergonovine is combined with caffeine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with azithromycin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when zaleplon is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when fosinopril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when amifostine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when flunisolide is combined with donepezil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with tiapride.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when betamethasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when amcinonide is combined with Demecarium.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with flunarizine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with eperisone.


The risk or severity of adverse effects can be increased when tropicamide is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with dantrolene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Articaine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with flunarizine.


The risk or severity of adverse effects can be increased when mesalamine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when perphenazine is combined with Articaine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with nalbuphine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when pancuronium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with diflunisal.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when theophylline is combined with pancuronium.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with dantrolene.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Flibanserin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when etizolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Articaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with estazolam.


The risk or severity of adverse effects can be increased when sulindac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Perospirone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlormezanone.


The risk or severity of adverse effects can be increased when aspirin is combined with DESONIDE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with desipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when secobarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when levorphanol is combined with meclizine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when methysergide is combined with Pazopanib.


The risk or severity of adverse effects can be increased when imipramine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when proparacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nabumetone is combined with flunisolide.


The risk or severity of adverse effects can be increased when ATROPINE is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Halazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Tolcapone.


The risk or severity of adverse effects can be increased when phenazopyridine is combined with prilocaine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when etizolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when penbutolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when zaleplon is combined with zopiclone.


The risk or severity of adverse effects can be increased when docetaxel is combined with Fulvestrant.


The risk or severity of adverse effects can be increased when cabergoline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when diclofenac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Micafungin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with 3,4-Dihydroxybenzaldehyde.


The risk or severity of adverse effects can be increased when ibuprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with nifedipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when prazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when clomipramine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when triamterene is combined with brimonidine.


The risk or severity of adverse effects can be increased when halothane is combined with Aliskiren.


The risk or severity of adverse effects can be increased when triamterene is combined with sotalol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with halothane.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with spironolactone.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Mometasone.


The risk or severity of adverse effects can be increased when nilvadipine is combined with propofol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with selegiline.


The risk or severity of adverse effects can be increased when flurazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Escitalopram.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when promazine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when bromocriptine is combined with mequitazine.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when tiapride is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with thalidomide.


The risk or severity of adverse effects can be increased when butorphanol is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when fosinopril is combined with methyldopa.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with dibucaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with metolazone.


The risk or severity of adverse effects can be increased when rasagiline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when procaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when docetaxel is combined with Abiraterone.


The risk or severity of adverse effects can be increased when losartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with thiamylal.


The risk or severity of adverse effects can be increased when proparacaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Paliperidone is combined with procaine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with indomethacin.


The risk or severity of adverse effects can be increased when butalbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when sulfadiazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when thioridazine is combined with midazolam.


The risk or severity of adverse effects can be increased when butorphanol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when oxazepam is combined with zopiclone.


The risk or severity of adverse effects can be increased when doxazosin is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with sertraline.


The risk or severity of adverse effects can be increased when amodiaquine is combined with mefloquine.


The risk or severity of adverse effects can be increased when azelastine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Eprosartan.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with lithium ion.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with amobarbital.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with simvastatin.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with HEROIN.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with etizolam.


The risk or severity of adverse effects can be increased when loxapine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with nitrazepam.


The risk or severity of adverse effects can be increased when dyclonine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Halazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when dyclonine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when milrinone is combined with mesalamine.


The risk or severity of adverse effects can be increased when morphine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with leflunomide.


The risk or severity of adverse effects can be increased when procyclidine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with felodipine.


The risk or severity of adverse effects can be increased when bepridil is combined with Pipamperone.


The risk or severity of adverse effects can be increased when norepinephrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with pentazocine.


The risk or severity of adverse effects can be increased when scopolamine is combined with nefazodone.


The risk or severity of adverse effects can be increased when spironolactone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when oxycodone is combined with topiramate.


The risk or severity of adverse effects can be increased when dibucaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when nilvadipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ethosuximide is combined with desipramine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with estrone.


The risk or severity of adverse effects can be increased when estrone is combined with decamethonium.


The risk or severity of adverse effects can be increased when nitric oxide is combined with losartan.


The risk or severity of adverse effects can be increased when propofol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nystatin is combined with gabapentin.


The risk or severity of adverse effects can be increased when Metixene is combined with butorphanol.


The risk or severity of adverse effects can be increased when propofol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with thioridazine.


The risk or severity of adverse effects can be increased when propofol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with quinapril.


The risk or severity of adverse effects can be increased when methazolamide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Salsalate.


The risk or severity of adverse effects can be increased when halothane is combined with Bretylium.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with bumetanide.


The risk or severity of adverse effects can be increased when apomorphine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Butethal is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Butethal is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when vincristine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when dibucaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when mecamylamine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when isoflurane is combined with bumetanide.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when isoflurane is combined with quinapril.


The risk or severity of adverse effects can be increased when apomorphine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when isoflurane is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when irbesartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with captopril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with minoxidil.


The risk or severity of adverse effects can be increased when glutethimide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with cilazapril.


The risk or severity of adverse effects can be increased when Phenelzine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when amiodarone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with potassium ion.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Perospirone.


The risk or severity of adverse effects can be increased when losartan is combined with Telmisartan.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when losartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when resveratrol is combined with salicylamide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when metaproterenol is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when pimozide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when tolmetin is combined with alclofenac.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with nadolol.


The risk or severity of adverse effects can be increased when nilvadipine is combined with triamterene.


The risk or severity of adverse effects can be increased when sotalol is combined with fosinopril.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with levodopa.


The risk or severity of adverse effects can be increased when butabarbital is combined with trimipramine.


The risk or severity of adverse effects can be increased when ritodrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when quazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with reserpine.


The risk or severity of adverse effects can be increased when imipramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when sevoflurane is combined with timolol.


The risk or severity of adverse effects can be increased when meperidine is combined with clonidine.


The risk or severity of adverse effects can be increased when triazolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when metoprolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when diazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when brotizolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when brotizolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when metoprolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when clorazepate is combined with sevoflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with levodopa.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Butoconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with salicylamide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when clorazepate is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when midazolam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with cinnarizine.


The risk or severity of adverse effects can be increased when propranolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when bromazepam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Artemether is combined with nimodipine.


The risk or severity of adverse effects can be increased when propranolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when propranolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with formoterol.


The risk or severity of adverse effects can be increased when clorazepate is combined with procaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with trimipramine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tretinoin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when haloperidol is combined with levorphanol.


The risk or severity of adverse effects can be increased when epirizole is combined with alclofenac.


The risk or severity of adverse effects can be increased when triprolidine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when meclizine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Asenapine.


The risk or severity of adverse effects can be increased when diltiazem is combined with nifedipine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with butamben.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when methylene blue is combined with oxycodone.


The risk or severity of adverse effects can be increased when doxazosin is combined with Bretylium.


The risk or severity of adverse effects can be increased when cerulenin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Icatibant is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when losartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Torasemide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with ethotoin.


The risk or severity of adverse effects can be increased when baclofen is combined with ethosuximide.


The risk or severity of adverse effects can be increased when diclofenac is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when brotizolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when celecoxib is combined with salicylamide.


The risk or severity of adverse effects can be increased when zaleplon is combined with imipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with loratadine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when methylene blue is combined with droxidopa.


The risk or severity of adverse effects can be increased when Agomelatine is combined with clemastine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with fenbufen.


The risk or severity of adverse effects can be increased when atenolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Halazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when pentazocine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when clorazepate is combined with baclofen.


The risk or severity of adverse effects can be increased when diclofenac is combined with difluprednate.


The risk or severity of adverse effects can be increased when sulpiride is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when clorazepate is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ondansetron is combined with butalbital.


The risk or severity of adverse effects can be increased when meclizine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when valsartan is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when tizanidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with perphenazine.


The risk or severity of adverse effects can be increased when propranolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nicergoline is combined with tacrolimus.


The risk or severity of adverse effects can be increased when Palbociclib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Tramadol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when butabarbital is combined with doxepin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Tramadol is combined with triazolam.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with nefazodone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with clemastine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with lidocaine.


The risk or severity of adverse effects can be increased when atenolol is combined with nadolol.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when midazolam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Cariprazine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with procaine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when temazepam is combined with procaine.


The risk or severity of adverse effects can be increased when nicergoline is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when temazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when epirizole is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when epirizole is combined with Halobetasol.


The risk or severity of adverse effects can be increased when nicergoline is combined with doxycycline.


The risk or severity of adverse effects can be increased when nicergoline is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with protriptyline.


The risk or severity of adverse effects can be increased when butabarbital is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when meprobamate is combined with glutethimide.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with halcinonide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with cetirizine.


The risk or severity of adverse effects can be increased when indomethacin is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when ketamine is combined with butalbital.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when zopiclone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when morphine is combined with felbamate.


The risk or severity of adverse effects can be increased when tolmetin is combined with alclometasone.


The risk or severity of adverse effects can be increased when paroxetine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ethosuximide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when trandolapril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when codeine is combined with lidocaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when methadone is combined with prilocaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with formestane.


The risk or severity of adverse effects can be increased when Tolcapone is combined with bumetanide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with quinapril.


The risk or severity of adverse effects can be increased when Tolcapone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when oxazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nilvadipine.


The risk or severity of adverse effects can be increased when oxazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when lithium ion is combined with meclizine.


The risk or severity of adverse effects can be increased when meperidine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when glutethimide is combined with clonidine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when loxapine is combined with lorazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when nitrazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when codeine is combined with isoflurane.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with flutamide.


The risk or severity of adverse effects can be increased when codeine is combined with ethotoin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with methadone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Apremilast is combined with leflunomide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Mometasone.


The risk or severity of adverse effects can be increased when amifostine is combined with morphine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with etizolam.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with HEROIN.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when duloxetine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when selegiline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when selegiline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when duloxetine is combined with promethazine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with baclofen.


The risk or severity of adverse effects can be increased when Arotinolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tretinoin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ethotoin.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with meperidine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with prilocaine.


The risk or severity of adverse effects can be increased when quazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Salsalate is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with protriptyline.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with cetirizine.


The risk or severity of adverse effects can be increased when methadone is combined with benzocaine.


The risk or severity of adverse effects can be increased when methadone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when clozapine is combined with butorphanol.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with celiprolol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with flunarizine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with indapamide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with timolol.


The risk or severity of adverse effects can be increased when dyclonine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with naratriptan.


The risk or severity of adverse effects can be increased when thioguanine is combined with leflunomide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when lithium ion is combined with clonazepam.


The risk or severity of adverse effects can be increased when buspirone is combined with levodopa.


The risk or severity of adverse effects can be increased when buspirone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when trazodone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when tetracycline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when buspirone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when buspirone is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when buspirone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when buspirone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when thiopental is combined with tiapride.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nilvadipine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Ramelteon is combined with duloxetine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when temazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with trimipramine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when perphenazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when epoprostenol is combined with pramipexole.


The risk or severity of adverse effects can be increased when ibudilast is combined with diflunisal.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when sulfamethoxazole is combined with prilocaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with linezolid.


The risk or severity of adverse effects can be increased when Halazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with pimozide.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Etomidate.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with bupivacaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when furosemide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with loxapine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when cabergoline is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when propoxyphene is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when cabergoline is combined with Escitalopram.


The risk or severity of adverse effects can be increased when propoxyphene is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when levodopa is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when midazolam is combined with promethazine.


The risk or severity of adverse effects can be increased when midazolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when triazolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when valsartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when Normethadone is combined with clemastine.


The risk or severity of adverse effects can be increased when pentazocine is combined with procarbazine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with furazolidone.


The risk or severity of adverse effects can be increased when midazolam is combined with Melatonin.


The risk or severity of adverse effects can be increased when biperiden is combined with Trospium.


The risk or severity of adverse effects can be increased when Escitalopram is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lidocaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when nicergoline is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nicergoline is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Nebivolol.


The risk or severity of adverse effects can be increased when rasagiline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when alprazolam is combined with dibucaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when gabapentin is combined with benzocaine.


The risk or severity of adverse effects can be increased when eperisone is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with zotepine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with triamterene.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with HEROIN.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when morphine is combined with Bretylium.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when pirenzepine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with procarbazine.


The risk or severity of adverse effects can be increased when minoxidil is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when amiodarone is combined with hydralazine.


The risk or severity of adverse effects can be increased when minoxidil is combined with doxazosin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with nortriptyline.


The risk or severity of adverse effects can be increased when diflunisal is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when minoxidil is combined with labetalol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with chloroquine.


The risk or severity of adverse effects can be increased when methysergide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Ifenprodil.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Melatonin is combined with efavirenz.


The risk or severity of adverse effects can be increased when nimodipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when oxazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with tiapride.


The risk or severity of adverse effects can be increased when sildenafil is combined with mecamylamine.


The risk or severity of adverse effects can be increased when irbesartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when ondansetron is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with etizolam.


The risk or severity of adverse effects can be increased when tolterodine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with meclizine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when ketamine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when morphine is combined with alprazolam.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Crizotinib.


The risk or severity of adverse effects can be increased when tolmetin is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when enflurane is combined with trimipramine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with digoxin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nimodipine.


The risk or severity of adverse effects can be increased when salicylamide is combined with epirizole.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Normethadone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when tolmetin is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when bromazepam is combined with quazepam.


The risk or severity of adverse effects can be increased when Articaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when morphine is combined with reserpine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Paliperidone.


The risk or severity of adverse effects can be increased when codeine is combined with tizanidine.


The risk or severity of adverse effects can be increased when tiagabine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when LISURIDE is combined with testosterone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with lomustine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when procarbazine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when cilazapril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when bromazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when gliclazide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when atenolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Sacubitril.


The risk or severity of adverse effects can be increased when azelastine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Pinaverium is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with nifedipine.


The risk or severity of adverse effects can be increased when suprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when Rotigotine is combined with papaverine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when phentolamine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when aspirin is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when metoclopramide is combined with lithium ion.


The risk or severity of adverse effects can be increased when thiothixene is combined with ethotoin.


The risk or severity of adverse effects can be increased when thiothixene is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when thiothixene is combined with prilocaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with pargyline.


The risk or severity of adverse effects can be increased when meprobamate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when meprobamate is combined with promazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when prazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with trandolapril.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with carprofen.


The risk or severity of adverse effects can be increased when Eletriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when thioridazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when protriptyline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when tolmetin is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when amphotericin b is combined with thalidomide.


The risk or severity of adverse effects can be increased when rasagiline is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Eribulin.


The risk or severity of adverse effects can be increased when Caspofungin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with captopril.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when diazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with acebutolol.


The risk or severity of adverse effects can be increased when Icatibant is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ramipril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with alprazolam.


The risk or severity of adverse effects can be increased when cabergoline is combined with progesterone.


The risk or severity of adverse effects can be increased when pargyline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Melatonin is combined with clomipramine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when procaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Ruxolitinib.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when hydromorphone is combined with loxapine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with glutethimide.


The risk or severity of adverse effects can be increased when aminophylline is combined with pancuronium.


The risk or severity of adverse effects can be increased when desoximetasone is combined with malathion.


The risk or severity of adverse effects can be increased when estazolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when proparacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with triamterene.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when tolazoline is combined with dipyridamole.


The risk or severity of adverse effects can be increased when furazolidone is combined with droxidopa.


The risk or severity of adverse effects can be increased when Idelalisib is combined with toremifene.


The risk or severity of adverse effects can be increased when Flupentixol is combined with clonidine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with oxycodone.


The risk or severity of adverse effects can be increased when Normethadone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when rivastigmine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Clofarabine.


The risk or severity of adverse effects can be increased when cocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Remoxipride is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Halazepam.


The risk or severity of adverse effects can be increased when cocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with alclofenac.


The risk or severity of adverse effects can be increased when haloperidol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when propofol is combined with gabapentin.


The risk or severity of adverse effects can be increased when docetaxel is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with captopril.


The risk or severity of adverse effects can be increased when enalapril is combined with terazosin.


The risk or severity of adverse effects can be increased when propofol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when docetaxel is combined with etoposide.


The risk or severity of adverse effects can be increased when procaine is combined with butamben.


The risk or severity of adverse effects can be increased when Olmesartan is combined with carprofen.


The risk or severity of adverse effects can be increased when lorazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when lorazepam is combined with procaine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Nabilone is combined with prazosin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with scopolamine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when milrinone is combined with Olsalazine.


The risk or severity of adverse effects can be increased when HEROIN is combined with clemastine.


The risk or severity of adverse effects can be increased when temazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when butorphanol is combined with selegiline.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with brotizolam.


The risk or severity of adverse effects can be increased when tolmetin is combined with leflunomide.


The risk or severity of adverse effects can be increased when irbesartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Masoprocol is combined with resveratrol.


The risk or severity of adverse effects can be increased when butorphanol is combined with protriptyline.


The risk or severity of adverse effects can be increased when lithium ion is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when butorphanol is combined with cetirizine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Nebivolol.


The risk or severity of adverse effects can be increased when linezolid is combined with Perospirone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Imatinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when carvedilol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when promazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when buprenorphine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with equilin.


The risk or severity of adverse effects can be increased when clozapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when thiamylal is combined with loratadine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nicardipine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when ethotoin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when tizanidine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when thiamylal is combined with glutethimide.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when trazodone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with levodopa.


The risk or severity of adverse effects can be increased when tizanidine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Melatonin is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when nilvadipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when bromocriptine is combined with zafirlukast.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when clozapine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when PENTAERYTHRITOL TETRANITRATE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when bepridil is combined with Conivaptan.


The risk or severity of adverse effects can be increased when Vilazodone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when glutethimide is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when lorazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when meprobamate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when promazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when tizanidine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methadone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with desipramine.


The risk or severity of adverse effects can be increased when procyclidine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when gabapentin is combined with amobarbital.